1.Atkins D., Lichtenfels R., Seliger B. Heat shock proteins in renal cell carcinomas. Contrib Nephrol. 2005. 148:35–56.
Article
2.Gelb AB. Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997. 80:981–6.
3.Lichtenfels R., Kellner R., Bukur J., Beck J., Brenner W., Ackermann A, et al. Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma. Proteomics. 2002. 2:561–70.
Article
4.Storm FK., Mahvi DM., Gilchrist KW. Heat shock protein 27 overexpression in breast cancer lymph node metastasis. Ann Surg Oncol. 1996. 3:570–3.
Article
5.Arts HJ., Hollema H., Lemstra W., Willemse PH., De Vries EG., Kampinga HH, et al. Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis. Int J Cancer. 1999. 84:234–8.
6.Mese H., Sasaki A., Nakayama S., Yoshioka N., Yoshihama Y., Kishimoto K, et al. Prognostic significance of heat shock protein 27 (HSP27) in patients with oral squamous cell carcinoma. Oncol Rep. 2002. 9:341–4.
Article
7.Rocchi P., So A., Kojima S., Signaevsky M., Beraldi E., Fazli L, et al. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer. Cancer Res. 2004. 64:6595–602.
Article
8.Youm YH., Kim S., Bahk YY., Yoo TK. Proteomic analysis of androgen-independent growth in low and high passage human LNCaP prostatic adenocarcinoma cells. BMB Rep. 2008. 41:722–7.
Article
9.Sarto C., Valsecchi C., Magni F., Tremolada L., Arizzi C., Cor-dani N, et al. Expression of heat shock protein 27 in human renal cell carcinoma. Proteomics. 2004. 4:2252–60.
Article
10.Concannon CG., Orrenius S., Samali A. HSP27 inhibits cytochrome c-mediated caspase activation by sequestering both pro-caspase-3 and cytochrome c. Gene Expr. 2001. 9:195–201.
Article
11.Erkizan O., Kirkali G., Yorukoglu K., Kirkali Z. Significance of heat shock protein-27 expression in patients with renal cell carcinoma. Urology. 2004. 64:474–8.
Article
12.Oki Y., Younes A. Heat shock protein-based cancer vaccines. Expert Rev Vaccines. 2004. 3:403–11.
Article
13.Hoos A., Levey DL. Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications. Expert Rev Vaccines. 2003. 2:369–79.
Article
14.Miyake H., Muramaki M., Kurahashi T., Takenaka A., Fujisawa M. Expression of potential molecular markers in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. Urol Oncol. 2008. Epub ahead of print.
Article
15.Rocchi P., Beraldi E., Ettinger S., Fazli L., Vessella RL., Nelson C, et al. Increased HSP27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Cancer Res. 2005. 65:11083–93.
Article
16.Teimourian S., Jalal R., Sohrabpour M., Goliaei B. Down-regulation of HSP27 radiosensitizes human prostate cancer cells. Int J Urol. 2006. 13:1221–5.
Article
17.Choi CJ., Park DS., Oh KH. Prognostic significance of heat shock protein 70 expression in bladder tumor. Korean J Urol. 1997. 38:951–6.
18.Yoon GS. Expression of heat shock protein 27 and apoptosis in renal cell caecinomas. Korean J Pathol. 2006. 40:39–45.
19.Lee H., Kwon TK., Park JW., Lee KS. The study about expression and regulation mechanism of heat shock protein 70 by arisostatins A in Caki cell line of renal cell carcinoma. Korean J Urol. 2005. 46:181–9.
20.Jeong WJ., Song KH., Kim KJ. Expression of heat shock protein 70 in ipsilateral rat kidney with unilateral partial ureteral obstruction. Korean J Urol. 2002. 43:1065–9.
21.Park SH., Park K., Park YI. Effects of temperature change on heat shock protein 70 expression in rat testes. Korean J Urol. 2003. 44:186–91.